Dr. Jame Abraham | CureTalks
Jame Abraham, MD, FACP, is the Director of the Breast Oncology Program at Taussig Cancer Institute and co-director of the Cleveland Clinic Comprehensive Breast Cancer Program. Dr. Abraham is also a professor of medicine at Cleveland Clinic Lerner College of Medicine. As director of the Cleveland Clinic Breast Oncology Program, Dr. Abraham leads several national and local clinical trials to find better treatment options for early stage, metastatic, triple negative and her-2 positive breast cancer patients. He is the vice chair of the Research Review Committee for the National Surgical Adjuvant Breast and Bowel Project NSABP and a member of the scientific advisory board. He is the national Principal Investigator of the NSABP FB -10 (Neratinib and TDM-1) clinical trial for her-2 positive metastatic breast cancer.
Developments in Personalized Medicine and New Options in Breast Cancer Treatment
In this era of personalized medicine the standard "one dose fits all" approach to cancer care has been ineffective leading to treatment failures.…